$RENT Balance Sheet | Understand Stock

$RENT

$2.69 -$0.01 (0.37%) Close

$RENT Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jul 31, 2026	Q1 FY2026 As of Apr 30, 2026	Q4 FY2025 As of Jan 31, 2026	Q3 FY2025 As of Oct 31, 2025	Q2 FY2025 As of Jul 31, 2025	Q1 FY2025 As of Apr 30, 2025	Q4 FY2024 As of Jan 31, 2025	Q3 FY2024 As of Oct 31, 2024	Q2 FY2024 As of Jul 31, 2024	Q1 FY2024 As of Apr 30, 2024	Q4 FY2023 As of Jan 31, 2024	Q3 FY2023 As of Oct 31, 2023	Q2 FY2023 As of Jul 31, 2023	Q1 FY2023 As of Apr 30, 2023	Q4 FY2022 As of Jan 31, 2023	Q3 FY2022 As of Oct 31, 2022	Q2 FY2022 As of Jul 31, 2022	Q1 FY2022 As of Apr 30, 2022	Q4 FY2021 As of Jan 31, 2022	Q3 FY2021 As of Oct 31, 2021
Assets
Current assets:
Cash and cash equivalents
Restricted cash, current
Prepaid expenses and other current assets
Total current assets
Restricted cash
Rental product, net
Fixed assets, net
Intangible assets, net
Operating lease right-of-use assets
Other assets
Total assets
Liabilities and Stockholders’ Equity (Deficit)
Current liabilities:
Accounts payable
Accrued expenses and other current liabilities
Deferred revenue
Customer credit liabilities
Customer credit and gift card liabilities
Operating lease liabilities
Total current liabilities
Long-term debt, net
Operating lease liabilities
Warrant liability
Other liabilities
Total liabilities
Redeemable preferred stock, $0.001 par value; 0 shares authorized as of July 31, 2022 and January 31, 2022; 0 shares issued and outstanding as of July 31, 2022 and January 31, 2022; liquidation preference of $0.0 million as of July 31, 2022 and January 31, 2022
Stockholders’ equity (deficit)
Common stock, value, issued
Common Stock
Common Class A
Common Class B
Total common stock, value, issued

Preferred stock, $0.001 par value; no shares authorized as of July 31, 2026 and 10,000,000 shares authorized as of January 31, 2026; 0 shares issued and outstanding as of July 31, 2026 and January 31, 2026
Additional paid-in capital
Accumulated deficit
Total stockholders’ equity (deficit)
Total liabilities and stockholders’ equity (deficit)

Comments